China
Africa
Explore chapters and articles related to this topic
Anxiety
Published in Carolyn Torkelson, Catherine Marienau, Beyond Menopause, 2023
Carolyn Torkelson, Catherine Marienau
In conventional medicine, generalized anxiety disorder is usually treated with one of three groups of medications: SSRIs, SNRIs, and benzodiazepines. June and Arlena took medication that lessened their agitated and frenetic thoughts, minimizing their anxious state. However, these types of medications are not helpful for all women and are only partially beneficial for many. Practitioners often recommend a combination of medication and behavioral therapy. Cognitive-behavioral therapy with the right therapist can be a valuable resource for treating and rewiring your anxious brain.
The Development of Intervention Memory-Executive Function Exercise for Breast Cancer Survivors with Chemobrain
Published in Teuku Tahlil, Hajjul Kamil, Asniar, Marthoenis, Challenges in Nursing Education and Research, 2020
Hilman Syarif, Agung Waluyo, Yati Afiyanti, Muchtaruddin Mansyur, Kemala Rita
The MEFE intervention package consists of four face-to-face meeting sessions, one session per week. The number of sessions is determined based on consideration of the patient’s condition, including physical conditions such as fatigue and various residual side effects of chemotherapy, economic conditions, family support, and time spent by survivors. The authors of the intervention package have not found the ideal number of cognitive rehabilitation sessions for survivors of breast cancer. As comparative information, according to Oemarjoedi (2003) and Putranto (2016), stated that in general, cognitive behavioral therapy is carried out with an average of 12 sessions. However, the number of 12 sessions is very difficult to implement in Indonesia, because; too long, too expensive, too complicated, boring, and decreases the patient’s confidence in the therapist’s abilities. So that the counseling process does not require a long time, it is hoped that the counselor can continuously help and train the counselee to do self-help. Interventions that are too complicated and boring will result in a decrease in the interest of survivors to attend the training program.
Treatment of Psychological Disorders
Published in Mohamed Ahmed Abd El-Hay, Understanding Psychology for Medicine and Nursing, 2019
Behavior therapy refers to a number of therapeutic methods that are based on the principles of learning, and assume that maladaptive behaviors are learned ways of coping with stress and can be replaced by more appropriate adaptive responses through learning techniques. The achievement of insight is not a goal, and it is not necessary to ensure behavioral change in behavior therapy, e.g., a person with social phobia may overcome fears without having insight about their origin. Behavior therapies attempt to modify behaviors that are maladaptive in specific situations. The behaviors to be changed are specified, first, then the therapist and client prepare a specific treatment program, for the particular problem. Behavior therapy is usually a short duration therapy, lasting about 6–8 weeks. Behavior therapists are easy to train and training is usually cost-effective. Some of the important behavioral techniques will be described briefly.
Self-treatment attempt of tobacco use disorder with Melissa officinalis: a case report and brief review of literature
Published in Journal of Addictive Diseases, 2023
Baris Sancak, Gizem Dokuzlu, Ozan Özcan, Urun Ozer Agirbas
The authors could not find a study in the literature on the use of Melissa herb as a cigarette in the treatment of nicotine cessation. For this reason, nicotine patch replacement therapy, which he had benefited from in the past, was recommended to the patient. He continued to drink one cup of Melissa tea a day, as there was evidence that it could be beneficial in the nicotine cessation process. In addition, he was advised to do daily mindfulness exercises. The patient was treated with NRT for a month along with psychotherapy for three months. Nicotine patch replacement therapy was started with a dose of 21 mg/day in the first week and was reduced to 14 mg/day the following week. Next week it was used 7 mg/day and stopped, but then it was continued for another week when the patient felt moderate cravings. During the psychotherapy process, 12 weekly cognitive-behavioral therapy sessions, including psychoeducation, were applied. At the end of the treatment, the patient stated that he stopped consuming the Melissa herb as a tea. No return to use was reported by the patient at his six month follow up. However, he started to consume Melissa tea in the fifth month from time to time when he had an urge to smoke. The oral cotinine-sensitive strip test result applied to the patient was level 0 (0–6 Ng/mL).
Australian Consultant Pharmacists’ Potential Roles in Sleep Health Care: Exploring a New Avenue for Improving the Management of Insomnia
Published in Behavioral Sleep Medicine, 2022
Mariam M. Basheti, Minh Tran, Keith Wong, Christopher Gordon, Ronald Grunstein, Bandana Saini
Frequently deemed as barriers, time to provide the behavioral therapy and the funding to support the “extra” time spent by consultant pharmacists during HMRs/RMMRs were key factors that would need to be addressed by relevant national state bodies. Most participants stated that they do not have enough time to provide the first session of behavioral therapy in the initial patient consult as other health/medication issues would take precedence. However, identifying the need for behavioral treatment for insomnia and for de-prescribing sedative-hypnotics could be recommended to the patient’s GP as part of a routine HMR/RMMR and then having the collaborating GP refer the patient for a separate behavioral therapy session was regarded a suitable treatment arrangement. The separate behavioral therapy session could be paid for by the patient, their insurance or a general practice (given consultant pharmacists are often employed by practices to conduct medication review/education services for patients). Participants further highlighted the need for a few follow-up sessions to ensure patient adherence and elicit feedback, which could either be face-to-face or over the phone, depending on individual patient situation. Again, it was pointed out that a regular HMR/RMMR context does not allow for scheduled frequent follow-ups. Interestingly, none of the participants discussed the use of an online management approach, e.g., telehealth, sleep apps or e-coaching.
Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments
Published in Expert Opinion on Pharmacotherapy, 2022
Nonpharmacologic approaches are suggested first-line treatment in managing symptoms of OAB through behavioral therapies (e.g. pelvic floor muscle exercises and bladder training) alone or in combination with pharmacotherapy [1]. Although behavioral therapy can be highly effective, it is not well suited for all patients due to the time and effort needed for training on proper techniques [2]. Behavioral therapies place substantial burden on patients to maintain adherence, which makes pharmacotherapy a potentially more attractive avenue. Balancing the benefits and challenges with each pharmacotherapy to ensure improvement in symptoms and patient quality of life (QoL) can be difficult. The past several years have seen the development of new therapeutic options, including a plethora of devices intended to improve pelvic floor identification, control, and strength but without universal adoption of any individual or class of devices.